Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Cardiac Tissue Engineering Market Size Changed, over the years?
The market size for cardiac tissue engineering has seen significant expansion in the previous years. It is expected to rise from $0.67 billion in 2024 to $0.81 billion in 2025, with a compound annual growth rate (CAGR) of 19.7%. Factors that have boosted growth in this historical time frame encompass a deficit of organ donors, a rise in cardiovascular diseases, breakthroughs in biomaterials, increased investment in regenerative medicine, a surge in demand for personalized medicine, improvements in bioreactor systems, enhanced governmental funding for biomedical research, and an escalating emphasis on minimally invasive treatments.
How Much Will the Cardiac Tissue Engineering Market Be Worth in 2029?
In the coming years, the cardiac tissue engineering market is set to experience significant expansion, with expectations of reaching $1.64 billion in 2029, boasting a compound annual growth rate (CAGR) of 19.4%. The projected growth for this period can be traced back to factors such as the growing demand for customized cardiac treatments, emphasis on bioengineered heart tissues, the broadening scope of regenerative medicine applications, increased partnerships between biotech companies and academia, a surge in investment into preclinical testing platforms, and the increasing occurrence of chronic heart diseases. Key trends forecasted for this period involve the inclusion of AI in tissue engineering, progress in nanotechnology-based scaffolds, the creation of biodegradable hydrogels, advancements in 3D bioprinting precision, employing bioreactors for tissue maturation, and utilizing gene editing to enhance cardiac cells.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21129&type=smp
Which is the Largest Company in the Cardiac Tissue Engineering Market?
Major companies operating in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences
What Are the Main Market Drivers in the Cardiac Tissue Engineering Industry?
The growth of the cardiac tissue engineering market is predicted to be stimulated by an increasing frequency of cardiovascular diseases. The interdisciplinary field of cardiac tissue engineering is concentrated on the development of biological or bioartificial constructs for the repair, regrowth, or replacement of impaired heart tissue. Unhealthy lifestyle decisions, such as a poor diet, lack of physical activity, smoking, and growing obesity and diabetes rates, primarily drive the mounting occurrence of cardiovascular diseases. Biomaterials, cell-based therapies, and bioengineered tissues are developed by cardiac tissue engineering to mend or regenerate damaged heart muscle and bring back cardiac function in cardiovascular diseases. For instance, based on the data from the Centers for Disease Control and Prevention, a US governmental organization, in May 2023, the rate of coronary heart disease in women adults aged 18 and over slightly rose to 3.7% in 2023 from 3.6% in 2022. Hence, the escalating occurrence of cardiovascular diseases is contributing to the expansion of the cardiac tissue engineering market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21129&type=smp
How Is the Cardiac Tissue Engineering Market Segments Structured?
The cardiac tissue engineering market covered in this report is segmented –
1) By Product: Heart Valves, Vascular Grafts
2) By Material: Stem Cells, Scaffolds
3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications
4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users
Subsegments:
1) By Heart Valves: Bioprosthetic Heart Valves, Mechanical Heart Valves, Tissue-Engineered Heart Valves
2) By Vascular Grafts: Synthetic Vascular Grafts, Biologic Vascular Grafts, Tissue-Engineered Vascular Grafts
What Strategic Trends Are Transforming the Cardiac Tissue Engineering Market?
Top corporations in the cardiac tissue engineering market are prioritizing the development of technological innovation like 3D-engineered muscle tissues. This is to increase the precision and effectiveness of drug discovery for better treatments for cardiovascular diseases. 3D-engineered muscle tissues serve as bioengineered constructs that mimic human muscle’s structural and functional properties, predominantly used for drug testing and disease simulation. For example, in July 2022, biotech company Curi Bio Inc. from the US, introduced the Mantarray platform for human 3D heart and engineered skeletal muscle tissue (EMT) contractility analysis. The platform utilizes cutting-edge tissue culture methodologies to produce highly functional muscle tissues that imitate the mechanical attributes and behavior of natural muscle, thus providing a more precise drug testing model. This innovation aims to elevate therapeutic solutions development by enabling researchers to investigate muscle contraction, stimuli response, and cellular-level disease simulation.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report
Which Global Regions Offer the Highest Growth in the Cardiac Tissue Engineering Market?
North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21129
This Report Delivers Insight On:
1. How big is the cardiac tissue engineering market, and how is it changing globally?
2. Who are the major companies in the cardiac tissue engineering market, and how are they performing?
3. What are the key opportunities and risks in the cardiac tissue engineering market right now?
4. Which products or customer segments are growing the most in the cardiac tissue engineering market?
5. What factors are helping or slowing down the growth of the cardiac tissue engineering market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model